Jag Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Jag Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $181,421 - $221,224	262 New	262 $215,000
Q1 2023 Sep 01, 2023	SELL	$680.49 - $826.97 $4.22 Million - $5.13 Million	-6,201 Reduced 96.32%	237 $194,000
Q4 2022 Sep 07, 2023	BUY	$705.89 - $766.39 $4.53 Million - $4.92 Million	6,424 New	6,424 $4.63 Million
Q4 2022 Sep 01, 2023	BUY	$705.89 - $766.39 $4.54 Million - $4.93 Million	6,438 New	6,438 $4.64 Million
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $4.84 Million - $5.26 Million	6,863 New	6,863 $4.95 Million

1,488

85.7M

1.53M

1.44M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Jag Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Jag Capital Management, LLC with notifications on news.